Clinical trial Recruiting at 1 site Interventional Ages 18 and up

ACL reconstruction using a human cortical bone (Shark Screw®) versus a biocomposite interference screw

Official title: ACL Reconstruction With Human Allograft Cortical Bone Screw (Shark Screw®) or Biocomposite-interference Screws - a Prospective, Randomized, Controlled Trial.

Run by Bezirkskrankenhaus Schwaz · NCT06357091 · Data updated 2026-11-12

This trial will test whether using a human cortical bone screw (Shark Screw®) instead of a biocomposite interference screw reduces tunnel widening and keeps re-rupture rates low for people having ACL reconstruction.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorBezirkskrankenhaus Schwaz
Academic / other
Locations1 site (Schwaz, Tyrol)
StatusRecruiting
StartedFebruary 16, 2026
Main results expectedJanuary 31, 2034
Study endsJanuary 31, 2034
Registry record updatedJanuary 21, 2026
Trial IDNCT06357091 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people with an MRI-confirmed ACL rupture who are indicated for reconstruction within six months of injury and have an uninjured contralateral knee.

Probably not a fit

Patients with a prior ACL rupture on the same knee, primary bone disease, inflammatory disease, unstable meniscus, complete collateral ligament rupture, or early rerupture during follow-up are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with MRI-confirmed ACL rupture who need reconstructive surgery will receive graft fixation with either a human allogeneic cortical bone screw (Shark Screw®) or a biocomposite interference screw; outcomes will be compared over two years. Tunnel widening will be measured using MRI and CT at specified intervals and re-rupture rates will be recorded. Standard knee outcome questionnaires will be collected before surgery and at 6, 12, and 24 months after surgery. The trial focuses on whether the human cortical bone screw leads to less tunnel dilatation and similar or lower failure rates than the conventional biocomposite screw.

Why it matters

Potential benefit: If successful, the human cortical bone screw could reduce tunnel widening and potentially lower re-rupture risk, which may preserve bone stock and simplify any future revision surgery.

How similar studies have gone: Conventional interference-screw fixation is well established, but comparative evidence for human allogeneic cortical bone screws is limited, so this is a relatively novel comparative approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* MRI-verified rupture of the anterior cruciate ligament
* Indication for replacement surgery
* Surgery within 6 months of injury
* Uninjured contralateral knee

Exclusion Criteria:

* Previous rupture of the anterior cruciate ligament on the side to be operated on (rerupture)
* Primary bone disease
* inflammatory disease
* Unstable meniscus
* complete rupture of a collateral ligament
* early rerupture during the examination period (early rerupture)

Where it's running

  • Bezirkskrankenhaus Schwaz Betriebsgesellschaft m.b.H
    Schwaz, Tyrol, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.